Call for Research Proposals

Applications Due September 4, 2020

The 2020 DSF Research Grant Program is open!

Our Research Grant Program was established in 2010 to support investigator sponsored research in the field of Dravet syndrome, which historically has been critically underfunded. Our goal is to support and promote innovative approaches in Dravet syndrome research across disciplines to meet the critically important needs in patient care. Applicants should ensure their proposed project addresses the needs of the Dravet syndrome community and DSF’s mission to support research toward better treatments and a cure for Dravet syndrome. The peer review process is directed by the DSF Scientific Advisory Board (SAB) The SAB will receive, process, and evaluate submitted proposals. The program will support research from any field in Dravet syndrome, provided it is considered valued research at a recognized research institution. Applications for our 2020 Funding Cycle are due Friday, September 4, 2020.

DSF offers four types of funding: Research GrantsClinical Research GrantsClinician-Researcher Awards, and Postdoctoral Fellowships. Selection criteria are explained in each grant opportunity below. Applicants should be affiliated with a research or academic institution (excluding for-profit companies), may be US or foreign based, established in their field, and in good standing with their institution. Proposals are scored according to NIH guidelines based on the quality of preliminary data, research design, feasibility, investigator’s qualifications, and overall impact.

  • Research Grant Awards are intended for established, experienced, independent investigators affiliated with a research or academic institution whose proposed projects investigate hypotheses directly related to Dravet syndrome. Grants are awarded for $150,000 over 2 years, with indirect costs not to exceed 10% of the award. 2020 priority areas include:
    • Transformative research to enhance our understanding of the cellular, molecular, genetic and systems-level mechanisms that lead to Dravet syndrome, facilitating the continued investigation of disease-modifying or preventative strategies
    • Research that will encourage the development of novel therapies to prevent onset or halt the progression of the Dravet syndrome
    • Research focused on new, effective treatments for Dravet syndrome and/or its comorbidities
  • Clinical Research Grant Awards are intended for proposed projects that have a clinical focus and investigate hypotheses directly related to Dravet syndrome. Grants are awarded for $150,000 over 2 years, with indirect costs not to exceed 10% of the award. 2020 priority areas include:
    • Research that will encourage the development of novel therapies to prevent onset or halt the progression of the Dravet syndrome
    • Research focused on new, effective treatments for Dravet syndrome and/or its comorbidities
    • Research that helps identify patient trends, characteristics, epidemiology, or other clinical aspects of Dravet syndrome
  • Clinician-Researcher Awards support hypothesis-driven clinical research projects that have significant potential to advance our understanding of Dravet syndrome; slow or halt the progression of the disease, characteristics, or comorbidities of the disease; and/or reduce mortality. The projects must be patient-oriented, with the investigator directly interacting with human subjects/patients. This includes studies such as therapeutic interventions or support/extension of existing clinical trials. Award funds of $75,000 for one year are to be used to support a minimum physician effort (salary and benefits) of 25%; funds may also be used to support a clinical trial specialist’s efforts or similar. No indirect costs are permitted.
  • Postdoctoral Fellowship Awards are designed to support early-career researchers under the mentorship of an independent investigator. These fellowships are awarded to qualified applicants whose proposed projects investigate hypotheses directly related to Dravet syndrome. Grants are awarded for $50,000, intended to support a full-time research effort with salary and benefits. No indirect costs are permitted.
By |2020-05-14T11:18:32-05:00May 15th, 2020|Categories: Research / Treatments|